首页> 美国卫生研究院文献>Clinical Kidney Journal >Real-world safety and effectiveness of sucroferric oxyhydroxide for treatment of hyperphosphataemia in dialysis patients: a prospective observational study

【2h】

Real-world safety and effectiveness of sucroferric oxyhydroxide for treatment of hyperphosphataemia in dialysis patients: a prospective observational study

机译：用于治疗透析患者高渗羟基血氧血清羟基血症的真实世界的安全性和有效性：透视观察研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

The iron-based phosphate binder (PB), sucroferric oxyhydroxide (SFOH), is indicated to control serum phosphorus levels in patients with chronic kidney disease on dialysis.

机译：表示铁基磷酸盐粘合剂（Pb），富发羟基氧化物（SFOH），以控制慢性肾疾病患者对透析的血清磷水平。

著录项

期刊名称 Clinical Kidney Journal
作者
Marc G Vervloet; Ioannis N Boletis; Angel L M de Francisco; Philip A Kalra; Markus Ketteler; Piergiorgio Messa; Manuela Stauss-Grabo; Anja Derlet; Sebastian Walpen; Amandine Perrin; Linda H Ficociello; Jacques Rottembourg; Christoph Wanner; Jorge B Cannata-Andía; Denis Fouque;
展开▼
作者单位

展开▼
年(卷),期 2021(14),7
年度 2021
页码 1770–1779
总页数 10
原文格式 PDF
正文语种
中图分类泌尿科学（泌尿生殖系疾病）;小儿泌尿科学;肾疾病;
关键词

机译：慢性肾病;末期肾病;血液透析;磷粘合剂;腹膜透析;

相似文献

外文文献
中文文献
专利

1. Cost Effectiveness of Sucroferric Oxyhydroxide Compared with Sevelamer Carbonate in the Treatment of Hyperphosphataemia in Patients Receiving Dialysis, from the Perspective of the National Health Service in Scotland [J] . Gutzwiller Florian S., Pfeil Alena M., Ademi Zanfina, PharmacoEconomics . 2015,第12期

机译：从苏格兰国家卫生服务局的角度看，羟基氧化超铁与碳酸司维拉姆相比在治疗透析患者高磷血症中的成本效益
2. Efficacy and safety of sucroferric oxyhydroxide in the treatment of hyperphosphataemia in chronic kidney disease in Asturias. FOSFASTUR study [J] . J. Emilio Sanchez-Alvarez, Elena Astudillo Cortés, Miguel Seras Mozas, Nefrologia . 2021,第1期

机译：羟基羟基氧化物在阿斯苏里亚斯慢性肾病中治疗高渗尿的疗效和安全性。 FOSCATTURER研究
3. Efficacy and safety of sucroferric oxyhydroxide compared with sevelamer hydrochloride in Japanese haemodialysis patients with hyperphosphataemia: A randomized, open-label, multicentre, 12-week phase III study [J] . Koiwa Fumihiko, Yokoyama Keitaro, Fukagawa Masafumi, Nephrology. . 2017,第4期

机译：与高磷脂血症的日本血液透析患者的盐酸福福酮氧化物相比，羟基氧化物的功效和安全性：随机，开放标签，多期，12周第II期研究
4. Application of Conditional Logistic Regression method in a prospective effectiveness comparative study among patients with Acute Ischemic Stroke [C] . Cai Jianxiong, Zhao Yuanqi, Guo Xianping, 2011 IEEE International Conference on Bioinformatics and Biomedicine Workshops . 2011

机译：条件对数回归方法在急性缺血性卒中患者前瞻性疗效比较研究中的应用
5. The Effectiveness of an Evidence-based Continuous Ambulatory Peritoneal Dialysis (CAPD) Retraining Program to Reduce Peritonitis among Incident CAPD Patients [D] . Leung, Wai Yin. 2019

机译：基于证据的连续动态腹膜透析（CAPD）再培训计划的有效性降低了事件CAPD患者的腹膜炎
6. Cost Effectiveness of Sucroferric Oxyhydroxide Compared with Sevelamer Carbonate in the Treatment of Hyperphosphataemia in Patients Receiving Dialysis from the Perspective of the National Health Service in Scotland [O] . Florian S. Gutzwiller, Alena M. Pfeil, Zanfina Ademi, -1

机译：从苏格兰国家卫生服务局的角度来看羟基氧化超铁与碳酸司维拉姆相比在治疗透析患者高磷血症中的成本效益
7. Real-world safety and effectiveness of sucroferric oxyhydroxide for treatment of hyperphosphataemia in dialysis patients: a prospective observational study [O] . Marc G Vervloet, Ioannis N Boletis, Angel L M de Francisco, 2021

机译：用于治疗透析患者高渗羟基血氧血清羟基血症的真实世界的安全性和有效性：透视观察研究

Real-world safety and effectiveness of sucroferric oxyhydroxide for treatment of hyperphosphataemia in dialysis patients: a prospective observational study

摘要

著录项

相似文献

相关主题

期刊订阅